durable responses to avelumab in patients with merkel cell carcinoma
Published 7 years ago • 160 plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
5:55
targetting pd-l1 with avelumab in metastatic merkel cell carcinoma
-
7:19
pembrolizumab yielded durable responses in patients with advanced merkel cell carcinoma
-
6:31
fda d.i.s.c.o.: avelumab in merkel cell carcinoma transcript
-
1:37
dr. kaufman discusses durable responses to avelumab in merkel cell carcinoma
-
6:31
fda d.i.s.c.o.: avelumab in merkel cell carcinoma
-
5:50
beating merkel cell carcinoma with immunotherapy
-
1:06
managing avelumab side effects in patients with merkel cell carcinoma
-
1:34
javelin merkel 200: avelumab for metastatic merkel cell carcinoma
-
2:03
avelumab in merkel cell carcinoma – updates from asco 2017
-
3:09
new insights in merkel cell biology and treatment
-
0:52
what does skin cancer look like? merkel cell carcinoma #skincare #skincancer #cancer
-
4:31
treatment updates in merkel cell carcinoma
-
1:08
dr. kaufman on avelumab in merkel cell carcinoma
-
16:38
systemic treatment for merkel cell carcinoma
-
15:38
velocity vlog: advances in merkel cell carcinoma - therapeutic advances and the path forward
-
1:36
avelumab and pembrolizumab for the treatment of merkel cell carcinoma
-
57:21
clinical utility of a novel assay for tracking tumor burden in merkel cell carcinoma
-
13:15
velocity vlog: advances in merkel cell carcinoma - new treatment approaches
-
0:35
dr. kudchadkar on the fda approval of avelumab in merkel cell carcinoma